Review
Open access
Aug 2026
Factor XI Inhibition for Ischemic Stroke Secondary Prevention: Pharmacology, Clinical Evidence, and Future Directions
A narrative review integrates pathophysiological rationale, comparative pharmacology of all FXI‐targeting classes, trial evidence, and patient stratification, providing an up‐to‐date reference for FXI/FXIa inhibition in secondary ischemic stroke prevention.
F. Ferrari, R. F. Villa
· Journal of clinical pharmaco... · 0 citations